The listed company Equillium launches a cryptocurrency reserve strategy
ChainCatcher news, according to businesswire, Nasdaq-listed biotechnology company Equillium announced the launch of a cryptocurrency reserve strategy, integrating the cryptocurrency funding reserve strategy as part of its broader financial and growth objectives.
The company has a total cash and cash equivalents of approximately $11.5 million as of June 30, 2025, and has not yet disclosed which digital currencies it will purchase.
ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.







